ALPHA TRIBE

Lincoln Pharmaceuticals LimitedBoard Meeting, 28-05-2026: Outcome of Board Meeting

28-05-2026 | 05:09 pm

Lincoln Pharma reports FY26 consolidated net profit of Rs 87.89 Cr (up 6.74%) and revenue of Rs 704.48 Cr (up 9.10%). The board proposed a final dividend of ₹1.80/share for FY26. Company targets Rs 1,000 Cr revenue in 3 years.

No comments yet. Be the first to comment!

All announcements from Lincoln Pharmaceuticals Limited